Johnson & Johnson

JOHNSON & JOHNSON NEWSROOM (1 press releases)

Advanced Filtering & Sorting Options:

Sandoz begins phase III studies in the United States for biosimilar epoetin alfa

PRESS RELEASE -- 3, November 2012

Holzkirchen, Germany, 3-11-2012 — /europawire.eu/ — Sandoz, the global leader in biosimilars, has started patient enrolment in a late stage clinical trial in the United States for its biosimilar epoetin alfa. The Phase III study will compare safety and efficacy of … Read the full press release